Subscribe
shutterstock_1940448004_hjbc
HJBC / Shutterstock.com
18 August 2022AmericasStaff Writer

French healthcare company makes $1.2bn AI drug discovery deal

Partnership with San Francisco-based software biotech initially focuses on compounds for five targets | Company uses machine learning to enable structure-based drug design.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Medtech
PTAB invalidates Sanofi injector patent
1 April 2021   Mylan Pharmaceuticals has succeeded in getting the Patent Trial and Appeal board (PTAB) to invalidate an injector patent held by French pharmaceutical company Sanofi
Americas
Sanofi unit takes CSL to court over haemophilia therapy
5 March 2020   Biotech company Bioverativ has accused CSL Behring of infringing three patents covering its haemophilia B treatment Alprolix.
Big Pharma
French pharma firm inks deal with tech provider
11 October 2022   The partnership aims to progress drug discovery and development | Tech platform accelerates trials and provides higher quality trial data.


Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024

Editor's picks

Europe
UPC confirms validity of Edwards Lifesciences heart valve tech patent
23 July 2024
Americas
New-look WIPR Leaders 2024 is ‘most rigorous’ yet
2 July 2024
Americas
Earthquake Chevron: A massive shock to the system?
2 July 2024
Americas
Amarin wins appeal to advance ‘skinny label’ suit over Hikma generic
27 June 2024
Biotechnology
Guardant Health files suit against Tempus AI
13 June 2024
Big Pharma
Roche fires lawsuit at Sinocare unit over blood glucose test strip patents
6 June 2024

More on this story

Medtech
PTAB invalidates Sanofi injector patent
1 April 2021   Mylan Pharmaceuticals has succeeded in getting the Patent Trial and Appeal board (PTAB) to invalidate an injector patent held by French pharmaceutical company Sanofi
Americas
Sanofi unit takes CSL to court over haemophilia therapy
5 March 2020   Biotech company Bioverativ has accused CSL Behring of infringing three patents covering its haemophilia B treatment Alprolix.
Big Pharma
French pharma firm inks deal with tech provider
11 October 2022   The partnership aims to progress drug discovery and development | Tech platform accelerates trials and provides higher quality trial data.

More on this story

Medtech
PTAB invalidates Sanofi injector patent
1 April 2021   Mylan Pharmaceuticals has succeeded in getting the Patent Trial and Appeal board (PTAB) to invalidate an injector patent held by French pharmaceutical company Sanofi
Americas
Sanofi unit takes CSL to court over haemophilia therapy
5 March 2020   Biotech company Bioverativ has accused CSL Behring of infringing three patents covering its haemophilia B treatment Alprolix.
Big Pharma
French pharma firm inks deal with tech provider
11 October 2022   The partnership aims to progress drug discovery and development | Tech platform accelerates trials and provides higher quality trial data.

More features

Chinese biotech takes out US rival’s nucleic acid patent at PTAB
Attorney v examiner: Navigating patenting's AI tools ‘arms race’
Lewis Roca promotes tech expert to managing partner
Panitch Schwarze brings in molecular biologist
US targets ‘product hopping’ with biologic litigation curbs
UPC confirms validity of Edwards Lifesciences heart valve tech patent
ITC concludes row over biotech lab equipment between US and German rivals
UKIPO launches ‘revolutionary’ patent filing and AI tool